- Smith-Lemli-Opitz syndrome
Infobox_Disease
Name = Smith-Lemli-Opitz syndrome
Caption =7-Dehydrocholesterol
DiseasesDB = 12223
ICD10 = ICD10|Q|87|1|q|80
ICD9 = ICD9|759.89
ICDO =
OMIM = 270400
MedlinePlus =
eMedicineSubj = ped
eMedicineTopic = 2117
MeshID = D019082Smith-Lemli-Opitz syndrome (also SLOS, or 7-dehydrocholesterol reductase deficiency) is a metabolic and developmental disorder that affects many parts of the body.
Presentation
This condition is characterized by distinctive facial features, small head size (
microcephaly ),mental retardation or learning disabilities, and behavioral problems. Malformations of theheart ,lung s,kidney s,gastrointestinal tract , andgenitalia are also common. Infants with Smith-Lemli-Opitz syndrome have weak muscle tone (hypotonia ), experience feeding difficulties, and tend to grow more slowly than other infants. Most affected individuals have fused second and third toes (syndactyly ), and some have extra fingers or toes (polydactyly ).Genetic prevalence
"Smith-Lemli-Opitz syndrome" affects an estimated 1 in 20,000 to 40,000 births. It is most common in Caucasians of European ancestry, but very rare among African and Asian populations.
This disorder is inherited in an
autosomal recessive pattern, which means two copies of thegene must be inherited to have the disorder.Mutations in the "DHCR7 "gene cause Smith-Lemli-Opitz syndrome. The "DHCR7" gene makes anenzyme called7-dehydrocholesterol reductase . This enzyme is responsible for the final step in the production ofcholesterol . Cholesterol is an essential nutrient that is necessary for normal embryonic development. Cholesterol is also a structural component ofcell membrane s and the protective substance coveringnerve cell s (myelin ). Additionally, cholesterol plays an important role in the production of certainhormone s and digestive acids.Mutations in the "DHCR7" gene reduce or eliminate the activity of
7-dehydrocholesterol reductase, preventing cells from producing enough cholesterol. A lack of this enzyme also allows potentially toxic byproducts of cholesterol production to build up in the blood and other tissues. The combination of low cholesterol levels and an accumulation of other substances likely disrupts the growth and development of many body systems. It is not known, however, how this disturbance in cholesterol production leads to the specific features of Smith-Lemli-Opitz syndrome.Associated conditions
A 2006 study of 14 children with Smith-Lemli-Opitz syndrome reported that most children with SLOS have an
autism spectrum disorder . SLOS appears to have the most consistent relationship withautism of any single-gene disorder. [cite journal |journal=Am J Med Genet a |year=2006 |volume=140 |issue=14 |pages=1511–8 |title= The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome |author= Sikora DM, Pettit-Kekel K, Penfield J, Merkens LS, Steiner RD |doi=10.1002/ajmg.a.31294 |pmid=16761297]Notable cases
On July 24th, 2007 a jury awarded a Florida couple, Daniel and Amara Estrada, whose sons are afflicted with Smith-Lemli-Opitz syndrome, 21 million dollars in damages. The Estradas claimed that Dr. Boris Kousseff failed to diagnose their first son's genetic disorder, leading to them having another son with the disorder. [cite web |url=http://www.gainesville.com/article/20070724/LOCAL/707240325/-1/news |title=LOCAL - - Gainesville.com |accessdate=2007-09-01 |format= |work=]
References
ee also
External links
* [http://www.hopkinsmedicine.org/cmsl/SLOS_Web_Text.html#SLOS%20Summary Richard I. Kelley on SLOS]
*
Wikimedia Foundation. 2010.